Association between immune-related adverse events and survival in patients with renal cell carcinoma treated with nivolumab plus ipilimumab: immortal time bias-corrected analysis

Satoshi Washino, Suguru Shirotake, Hideki Takeshita, Masaharu Inoue, Yuji Miura, Yoji Hyodo, Makoto Kagawa, Keita Izumi, Masafumi Oyama, Satoru Kawakami, Kazutaka Saito, Yoh Matsuoka, Satsuki Taniuchi, Ayumi Shintani, Tomoaki Miyagawa